Lenox Wealth Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-130
Closed -$12K 976
2021
Q4
$12K Hold
130
﹤0.01% 489
2021
Q3
$16K Hold
130
﹤0.01% 400
2021
Q2
$22K Hold
130
﹤0.01% 343
2021
Q1
$24K Hold
130
﹤0.01% 288
2020
Q4
$26K Hold
130
﹤0.01% 275
2020
Q3
$29K Hold
130
﹤0.01% 233
2020
Q2
$25K Hold
130
﹤0.01% 258
2020
Q1
$20K Hold
130
﹤0.01% 264
2019
Q4
$11K Hold
130
﹤0.01% 407
2019
Q3
$9K Buy
+130
New +$8.56K ﹤0.01% 371

Other funds holding TDOC

Lenox Wealth Advisors's TDOC Position: Q1 2022 in Review

Lenox Wealth Advisors sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 130 shares — an estimated $12K sold.

Lenox Wealth Advisors first reported a position in TDOC in Q3 2019 and held it in 10 quarters. The position peaked at $29K in Q3 2020. 679 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Lenox Wealth Advisors reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Lenox Wealth Advisors sold 130 Teladoc Health shares in Q1 2022, an estimated $12K.
  • Lenox Wealth Advisors first reported a position in Teladoc Health in Q3 2019 and held it in 10 quarters.
  • Lenox Wealth Advisors's Teladoc Health position peaked at $29K in Q3 2020.
  • 679 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Lenox Wealth Advisors's 13F filing for Q1 2022, filed 14 Apr 2022.